Stay updated on PAAP for Pralsetinib in NSCLC and MTC Clinical Trial
Sign up to get notified when there's something new on the PAAP for Pralsetinib in NSCLC and MTC Clinical Trial page.

Latest updates to the PAAP for Pralsetinib in NSCLC and MTC Clinical Trial page
- Check2 days agoChange DetectedThe page revision was updated from v3.6.5 to v3.6.6, indicating a new build of the page. This change appears to reflect a minor, behind-the-scenes update rather than a modification to study details or user-facing content.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page revision label was updated from v3.6.4 to v3.6.5, indicating a newer version of the page for tracking purposes.SummaryDifference0.1%

- Check38 days agoChange DetectedThe page shows a revision tag updated from v3.6.3 to v3.6.4, indicating a new patch or update to the page or underlying system. This is a minor update and does not change the displayed study details or user-facing content.SummaryDifference0.1%

- Check59 days agoChange DetectedThe page's revision tag was updated from v3.6.2 to v3.6.3, indicating a routine deployment update rather than a change to the study content.SummaryDifference0.1%

- Check66 days agoChange DetectedThe page's revision label was updated from v3.6.0 to v3.6.2, replacing the previous build indicator with a newer minor platform update.SummaryDifference0.1%

- Check82 days agoChange DetectedNew Help/Information sections were added (How to Read a Study Record, Common Questions, How to Join a Study). The Intervention/Treatment label has been standardized, and the previous 'Intervention / Treatment' label and the 'Revision: v3.5.5' note were removed.SummaryDifference0.6%

Stay in the know with updates to PAAP for Pralsetinib in NSCLC and MTC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PAAP for Pralsetinib in NSCLC and MTC Clinical Trial page.